21 results on '"De Francesco,Adele"'
Number of results to display per page
Search Results
2. A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
- Author
-
Cafaro, Alessandro, primary, Foca, Flavia, additional, Nanni, Oriana, additional, Chiumente, Marco, additional, Coppola, Marina, additional, Baldo, Paolo, additional, Orzetti, Sabrina, additional, Enrico, Fiorenza, additional, Ladisa, Vito, additional, Lerose, Rosa, additional, Nardulli, Patrizia, additional, Maiolino, Piera, additional, Gradellini, Federica, additional, Gasbarro, Anna Rita, additional, Carrucciu, Gisella, additional, Provasi, Riccardo, additional, Cappelletto, Paola Cristina, additional, Pasqualini, Alessandra, additional, Vecchia, Stefano, additional, Veraldi, Marianna, additional, De Francesco, Adele Emanuela, additional, Crinò, Lucio, additional, Delmonte, Angelo, additional, and Masini, Carla, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study
- Author
-
Sultana, Janet, Giorgianni, Francesco, Scondotto, Giulia, Ientile, Valentina, Cananzi, Pasquale, Leoni, Olivia, Addario, Sebastiano Walter Pollina, De Sarro, Giovanbattista, De Francesco, Adele, Puzo, Maria Rosa, Renoux, Christel, and Trifirò, Gianluca
- Published
- 2020
- Full Text
- View/download PDF
4. Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study
- Author
-
Tallarico, Martina, primary, Palleria, Caterina, additional, Ruffolo, Livia, additional, Spagnuolo, Rocco, additional, Naturale, Maria Diana, additional, De Francesco, Adele Emanuela, additional, De Sarro, Caterina, additional, Romeo, Rossella, additional, Citraro, Rita, additional, Doldo, Patrizia, additional, Abenavoli, Ludovico, additional, Gallelli, Luca, additional, Luzza, Francesco, additional, Leo, Antonio, additional, and De Sarro, Giovambattista, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region
- Author
-
Gagliardi, Agnese, primary, Iaquinta, Francesco Salvatore, additional, Grembiale, Rosa Daniela, additional, De Sarro, Caterina, additional, Fabiano, Antonio, additional, Fraija, Domenico, additional, Palleria, Caterina, additional, Romeo, Rossella, additional, De Francesco, Adele Emanuela, additional, Naturale, Maria Diana, additional, Citraro, Rita, additional, Gallelli, Luca, additional, Leo, Antonio, additional, and De Sarro, Giovambattista, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources
- Author
-
Perrone, Valentina, primary, Veronesi, Chiara, additional, Dovizio, Melania, additional, Ancona, Domenica Daniela, additional, Andretta, Margherita, additional, Bartolini, Fausto, additional, Cavaliere, Arturo, additional, Chinellato, Alessandro, additional, Ciaccia, Andrea, additional, Cillo, Mariarosaria, additional, De Francesco, Adele, additional, Enieri, Nicola, additional, Ferrante, Fulvio, additional, Gentile, Simona, additional, Procacci, Cataldo, additional, Ubertazzo, Loredana, additional, Vercellone, Adriano, additional, Lucatelli, Domenico, additional, Procaccini, Michela, additional, and Degli Esposti, Luca, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources
- Author
-
Perrone,Valentina, Veronesi,Chiara, Dovizio,Melania, Ancona,Domenica Daniela, Andretta,Margherita, Bartolini,Fausto, Cavaliere,Arturo, Chinellato,Alessandro, Ciaccia,Andrea, Cillo,Mariarosaria, De Francesco,Adele, Enieri,Nicola, Ferrante,Fulvio, Gentile,Simona, Procacci,Cataldo, Ubertazzo,Loredana, Vercellone,Adriano, Lucatelli,Domenico, Procaccini,Michela, Degli Esposti,Luca, Perrone,Valentina, Veronesi,Chiara, Dovizio,Melania, Ancona,Domenica Daniela, Andretta,Margherita, Bartolini,Fausto, Cavaliere,Arturo, Chinellato,Alessandro, Ciaccia,Andrea, Cillo,Mariarosaria, De Francesco,Adele, Enieri,Nicola, Ferrante,Fulvio, Gentile,Simona, Procacci,Cataldo, Ubertazzo,Loredana, Vercellone,Adriano, Lucatelli,Domenico, Procaccini,Michela, and Degli Esposti,Luca
- Abstract
Valentina Perrone,1 Chiara Veronesi,1 Melania Dovizio,1 Domenica Daniela Ancona,2 Margherita Andretta,3 Fausto Bartolini,4 Arturo Cavaliere,5 Alessandro Chinellato,6 Andrea Ciaccia,7 Mariarosaria Cillo,8 Adele De Francesco,9 Nicola Enieri,6 Fulvio Ferrante,10 Simona Gentile,11 Cataldo Procacci,2 Loredana Ubertazzo,12 Adriano Vercellone,13 Domenico Lucatelli,14 Michela Procaccini,14 Luca Degli Esposti1 1CliCon S.r.l., Società Benefit-Health, Economics & Outcomes Research, Bologna, Italy; 2Dipartimento Farmaceutico, ASL BAT, Andria, Italy; 3UOC Assistenza Farmaceutica Territoriale, Azienda ULSS 8 Berica, Vicenza, Italy; 4Dipartimento Farmaceutico, USL Umbria 2, Terni, Italy; 5Farmaceutica Aziendale, ASL Viterbo, Viterbo, Italy; 6Unità Operativa Farmacia Ospedaliera, ULSS 3 Serenissima, Mestre, Italy; 7ASL Foggia, Foggia, Italy; 8Dipartimento Farmaceutico, ASL Salerno, Salerno, Italy; 9Azienda Ospedaliero-Universitaria âMater Dominiâ, Catanzaro, Italy; 10ASL Frosinone, Frosinone, Italy; 11Direzione Generale per la Salute, Campobasso, Italy; 12ASL Roma 4, Civitavecchia, Roma, Italy; 13ASL Napoli 3 sud, Napoli, Italy; 14Angelini Pharma, Roma, ItalyCorrespondence: Valentina Perrone, CliCon S.r.l., Società Benefit-Health, Economics & Outcomes Research, Via Murri 9, Bologna, 40137, Italy, Tel +39 3450316494, Email valentina.perrone@clicon.itPurpose: A retrospective analysis was conducted to estimate the number of patients with focal epilepsy and drug-resistant epilepsy (DRE) and their characteristics, the therapeutic patterns, the consumption of health resources in a real-world Italian setting.Patients and Methods: A retrospective study was carried out on the administrative databases of a sample of Italian Health Departments, covering approximately 8.7 million health-assisted individuals. All adult patients with at least one hospitalization for focal epilepsy and an electroencephalogram (between 01/2010 and 12/2019), and at least one prescription of antiseizu
- Published
- 2022
8. Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in Italy
- Author
-
Perrone, Valentina, primary, Dovizio, Melania, additional, Veronesi, Chiara, additional, Citraro, Rita, additional, De Francesco, Adele, additional, Dell’Orco, Stefania, additional, Di Manno, Gianluca, additional, Paciello, Arrigo, additional, Resta, Anna Maria, additional, Quarta, Fabrizio, additional, Ferrante, Nicola, additional, Ritrovato, Daniela, additional, and Degli Esposti, Luca, additional
- Published
- 2022
- Full Text
- View/download PDF
9. Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
- Author
-
Bellone, Marco, primary, Pradelli, Lorenzo, additional, Molica, Stefano, additional, De Francesco, Adele Emanuela, additional, Ghislieri, Daniela, additional, Guardalben, Emanuele, additional, and Caputo, Antonietta, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility
- Author
-
Trecarichi, Enrico Maria, Mazzitelli, Maria, Serapide, Francesca, Pelle, Maria Chiara, Tassone, Bruno, Arrighi, Eugenio, Perri, Graziella, Fusco, Paolo, Scaglione, Vincenzo, Davoli, Chiara, Lionello, Rosaria, La Gamba, Valentina, Marrazzo, Giuseppina, Busceti, Maria Teresa, Giudice, Amerigo, Ricchio, Marco, Cancelliere, Anna, Lio, Elena, Procopio, Giada, Costanzo, Francesco Saverio, Foti, Daniela Patrizia, Matera, Giovanni, Torti, Carlo, Laganà, Domenico, Petullà, Maria, Bertucci, Bernardo, Quirino, Angela, Barreca, Giorgio Settimo, Giancotti, Aida, Gallo, Luigia, Lamberti, Angelo, Liberto, Maria Carla, Marascio, Nadia, De Francesco, Adele Emanuela, and IDTM UMG COVID-19 Group
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,China ,Epidemiology ,Article ,COVID-19 ,Infectious diseases ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Lymphopenia ,Pandemic ,medicine ,Humans ,030212 general & internal medicine ,Hospital Mortality ,Aged ,Aged, 80 and over ,Multidisciplinary ,Hypernatremia ,Proportional hazards model ,business.industry ,Interleukin-6 ,SARS-CoV-2 ,Mortality rate ,Outbreak ,medicine.disease ,Long-Term Care ,Nursing Homes ,Hospitalization ,Long-term care ,030104 developmental biology ,Cardiovascular Diseases ,Cohort ,Female ,business ,Cytokine Release Syndrome ,Cohort study - Abstract
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from China all over the world and many COVID-19 outbreaks have been reported in long-term care facilities (LCTF). However, data on clinical characteristics and prognostic factors in such settings are scarce. We conducted a retrospective, observational cohort study to assess clinical characteristics and baseline predictors of mortality of COVID-19 patients hospitalized after an outbreak of SARS-CoV-2 infection in a LTCF. A total of 50 patients were included. Mean age was 80 years (SD, 12 years), and 24/50 (57.1%) patients were males. The overall in-hospital mortality rate was 32%. At Cox regression analysis, significant predictors of in-hospital mortality were: hypernatremia (HR 9.12), lymphocyte count
- Published
- 2020
11. Integrated Management Of Chronic Diseases In Multiunit Shared Surgery
- Author
-
De Francesco, Adele Emanuela, De Fina Mariarosanna, Mariacristina Zito, Esposito, Stefania, Monopoli, Cristina, and Giovambattista De Sarro
- Subjects
clinical governance, multidisciplinarity, effectiveness, IMiDs - Abstract
Chronic diseases have a significant impact on health and socio-health care, in terms of premature death, chronicity or disability. Numerous scientific evidences have shown that some pathologies affecting the immune system depend on common pathogenetic mechanisms in which the number of patients presenting with Rheumatological, Dermatological or Gastroenterological comorbidities ranges between 25% to 40%. The research was conducted through an expert panel, which share skills and knowledge about the management of IMiDs pathologies. The panellists suggested a new planning of the treatment path. They recommended the presence of the hospital pharmacist, who guarantees the safety of treatments. The study highlights how the multidisciplinary approach in the hospital setting is able to increase the effectiveness of treatments and at the same time reduce indirect costs
- Published
- 2020
- Full Text
- View/download PDF
12. Clinical Trial in Hospital Practice: Pharmacists Perspective and Risk Management Reflections
- Author
-
De Fina Mariarosanna, Zito Maria Cristina, Naturale Maria Diana, Esposito Stefania, and De Francesco Adele Emanuela
- Subjects
Clinical Trial, Research Pharmacist, Clinical risk management, Hospital Pharmacist, Cronbach's alfa Pharmacy Management - Abstract
In recent years the number of clinical trials has undergone a significant increase worldwide. In Europe the law n. UE 536/2014 represents an important turning point in the field of clinical trials of medicines. In an Italian national context characterized by profound revolutions and innovations, the hospital pharmacist plays an important role in the management of the protection of the human person, in terms of the rights, safety, dignity and well-being of the subjects enrolled in clinical trials. Objects of work:Evaluate the clinical trials conducted and the complexity of management from the hospital pharmacist's perspective and analyse the complexity of the trials conducted. Retrospective study was carried out at Mater Domini University Hospital in Catanzaro (Italy) during 01/01/2017- 31/12/2019. The delivery to the hospital pharmacy was recorded as index data. All clinical trials started in study period were included. In order to estimate the complexity of management, a questionnaire was developed and administrated to all authors involved to clinical trial management. The questionnaires results were calculated as average scores for individual items. The scale comprises 10 close ended, pretested, highly reliable questions. The complexity score of the trial was evaluated with Cronbach’s alfa test and Pearson correlation.In total, 94 clinical trials were started from 2017 to 2019, including 15 Therapeutic Area and 25 different Principal Investigator. In totally the Cronbach’s alfa for our complexity scale is 0.807. The Pearson correlation is particularly significant (p Objects of work:Evaluate the clinical trials conducted and the complexity of management from the hospital pharmacist's perspective and analyse the complexity of the trials conducted. Retrospective study was carried out at Mater Domini University Hospital in Catanzaro (Italy) during 01/01/2017- 31/12/2019. The delivery to the hospital pharmacy was recorded as index data. All clinical trials started in study period were included. In order to estimate the complexity of management, a questionnaire was developed and administrated to all authors involved to clinical trial management. The questionnaires results were calculated as average scores for individual items. The scale comprises 10 close ended, pretested, highly reliable questions. The complexity score of the trial was evaluated with Cronbach’s alfa test and Pearson correlation.In total, 94 clinical trials were started from 2017 to 2019, including 15 Therapeutic Area and 25 different Principal Investigator. In totally the Cronbach’s alfa for our complexity scale is 0.807. The Pearson correlation is particularly significant (pIn conclusion, this study provided a broad representation regarding the pharmacist's perception on role on the services provided. The pharmacist involved into clinical research study is essential for maintaining the highest standards for medication safety practices and ultimately, the quality, efficacy, and safety.taining the highest standards for medication safety practices and ultimately, the quality, efficacy, and safety.
- Published
- 2020
- Full Text
- View/download PDF
13. Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
- Author
-
Bellone,Marco, Pradelli,Lorenzo, Molica,Stefano, De Francesco,Adele Emanuela, Ghislieri,Daniela, Guardalben,Emanuele, Caputo,Antonietta, Bellone,Marco, Pradelli,Lorenzo, Molica,Stefano, De Francesco,Adele Emanuela, Ghislieri,Daniela, Guardalben,Emanuele, and Caputo,Antonietta
- Abstract
Marco Bellone,1 Lorenzo Pradelli,1 Stefano Molica,2 Adele Emanuela De Francesco,3 Daniela Ghislieri,4 Emanuele Guardalben,5 Antonietta Caputo4 1Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin, Italy; 2Dipartimento Onco-ematologico, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy; 3Hospital Pharmacy, Mater Domini Azienda Ospedaliero Universitaria, Catanzaro, Italy; 4Market Access Department, Roche SpA, Monza, Italy; 5Medical Department, Roche SpA, Monza, ItalyCorrespondence: Marco BelloneAdRes Health Economics and Outcomes Research, 17 Via Vittorio Alfieri, Turin 10121, ItalyTel +39 011 765-1239Email m.bellone@adreshe.comObjective: To assess the cost-effectiveness of obinutuzumab (O-chemo) in comparison to rituximab (R-chemo) in patients with untreated advanced follicular lymphoma (FL) at intermediate or high risk from an Italian National Health Service (NHS) perspective.Methods: A previously developed four-state Markov model was adapted to estimate lifetime clinical outcomes and costs of Italian patients with advanced FL and an FL international predictive index score ⥠2 in treatment with O-chemo and R-chemo. Life expectancy was derived from the GALLIUM and PRIMA clinical trials. Progression-free survival (PFS), early progressive disease (PD), and treatment duration were extrapolated by fitting parametric distributions to empirical data in GALLIUM and late PD to data in PRIMA. Expected survival was weighed by published utilities. Costs updated to 2020 Euros and health gains occurring after the first year were discounted at an annual 3% rate. Probabilistic sensitivity analysis (PSA) was carried out.Results: O-chemo was associated with an incremental survival increase (0.97 life-years [LYs]), even when weighted for quality (0.88 quality-adjusted LYs [QALYs]), and incremental costs (around ⬠15,000), driven by longer treatment during PFS state relative to R-chemo. The incremental cost-effectiveness rat
- Published
- 2021
14. Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
- Author
-
Iannone, Luigi Francesco, primary, Bennardo, Luigi, additional, Palleria, Caterina, additional, Roberti, Roberta, additional, De Sarro, Caterina, additional, Naturale, Maria Diana, additional, Dastoli, Stefano, additional, Donato, Luca, additional, Manti, Antonia, additional, Valenti, Giancarlo, additional, D’Amico, Domenico, additional, D’Attola, Santo, additional, De Francesco, Adele Emanuela, additional, Bosco, Vincenzo, additional, Donato Di Paola, Eugenio, additional, Nisticò, Steven Paul, additional, Citraro, Rita, additional, Russo, Emilio, additional, and De Sarro, Giovambattista, additional
- Published
- 2020
- Full Text
- View/download PDF
15. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy
- Author
-
Roberti, Roberta, primary, Iannone, Luigi Francesco, additional, Palleria, Caterina, additional, De Sarro, Caterina, additional, Spagnuolo, Rocco, additional, Barbieri, Maria Antonietta, additional, Vero, Ada, additional, Manti, Antonia, additional, Pisana, Valentina, additional, Fries, Walter, additional, Trifirò, Gianluca, additional, Naturale, Maria Diana, additional, Larussa, Tiziana, additional, De Francesco, Adele Emanuela, additional, Bosco, Vincenzo, additional, Donato di Paola, Eugenio, additional, Citraro, Rita, additional, Luzza, Francesco, additional, Bennardo, Luigi, additional, Rodinò, Stefano, additional, Doldo, Patrizia, additional, Spina, Edoardo, additional, Russo, Emilio, additional, and De Sarro, Giovambattista, additional
- Published
- 2020
- Full Text
- View/download PDF
16. How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016
- Author
-
Scondotto, Giulia, primary, Sultana, Janet, additional, Ientile, Valentina, additional, Ingrasciotta, Ylenia, additional, Fontana, Andrea, additional, Copetti, Massimiliano, additional, Mirabelli, Eliana, additional, Trombetta, Costantino J., additional, Rapisarda, Carlo, additional, Reibaldi, Michele, additional, Avitabile, Teresio, additional, Longo, Antonio, additional, Toro, Patricia Ibanez, additional, Vadalà, Maria, additional, Cillino, Salvatore, additional, Virgili, Gianni, additional, Gini, Rosa, additional, Leoni, Olivia, additional, Pollina Addario, Sebastiano Walter, additional, Cananzi, Pasquale, additional, La Cavera, Claudia, additional, Puzo, Maria Rosalia, additional, De Sarro, Giovambattista, additional, De Francesco, Adele, additional, and Trifirò, Gianluca, additional
- Published
- 2020
- Full Text
- View/download PDF
17. Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
- Author
-
Hirsh, Vera, primary, Pignata, Sandro, additional, Bersanelli, Melissa, additional, Gnetti, Letizia, additional, Azzoni, Cinzia, additional, Bottarelli, Lorena, additional, Gasparro, Donatello, additional, Leonardi, Francesco, additional, Silini, Enrico Maria, additional, Buti, Sebastiano, additional, Wennerberg, Erik, additional, Mediero, Aranzazu, additional, Cronstein, Bruce, additional, Formenti, Silvia, additional, Demaria, Sandra, additional, Vanpouille-Box, Claire, additional, Pilones, Karsten, additional, Rudqvist, Nils, additional, Diamond, Julie, additional, Morris, Zachary S., additional, Guy, Emily I., additional, Francis, David M., additional, Gressett, Monica M., additional, Armstrong, Eric A., additional, Huang, Shyhmin, additional, Gilles, Stephen D., additional, Korman, Alan J., additional, Hank, Jacquelyn A., additional, Hoefges, Anna, additional, Rakhmilevich, Alexander L., additional, Harari, Paul M., additional, Sondel, Paul M., additional, Hailemichael, Yared, additional, Overwijk, Willem W., additional, Straten, Per thor, additional, Lugli, Alessandro, additional, Dawson, Heather, additional, Blank, Annika, additional, Zlobec, Inti, additional, Fattore, Luigi, additional, Costantini, Susan, additional, Acunzo, Mario, additional, Romano, Giulia, additional, Nigita, Giovanni, additional, Laganà, Alessandro, additional, Malpicci, Debora, additional, Ruggiero, Ciro Francesco, additional, Pisanu, Maria Elena, additional, Noto, Alessia, additional, De Vitis, Claudia, additional, Croce, Carlo Maria, additional, Ascierto, Paolo Antonio, additional, Mancini, Rita, additional, Ciliberto, Gennaro, additional, Postow, Michael, additional, Luke, Jason, additional, Stroncek, David, additional, Castiello, Luciano, additional, Chen, Wenjing, additional, Jin, Ping, additional, Ren, Jiaqiang, additional, Sabatino, Marianna, additional, Ferrone, Soldano, additional, Duong, Connie PM, additional, Vetizou, Marie, additional, Zitvogel, Laurence, additional, Occelli, Marcella, additional, Cauchi, Carolina, additional, Sciancalepore, Grazia, additional, Lo Nigro, Cristiana, additional, Rovera, Michela, additional, Varamo, Chiara, additional, Vivenza, Daniela, additional, Seia, Zelda, additional, Palazzini, Stefania, additional, Errico, Fabiana, additional, Basso, Davide, additional, Quaranta, Laura, additional, Forte, Giuseppe, additional, Lavagna, Fulvio, additional, Violante, Silvia, additional, Bosio, Paolo, additional, Lattanzio, Laura, additional, Merlano, Marco Carlo, additional, Moogk, Duane, additional, Zhong, Shi, additional, Yu, Zhiya, additional, Liadi, Ivan, additional, Rittase, William, additional, Fang, Victoria, additional, Dougherty, Janna, additional, Perez-Garcia, Arianne, additional, Osman, Iman, additional, Zhu, Cheng, additional, Varadarajan, Navin, additional, Restifo, Nicholas P., additional, Frey, Alan, additional, Krogsgaard, Michelle, additional, Balatoni, Timea, additional, Moho, Anita, additional, Sebestyén, Timea, additional, Varga, Anita, additional, Oláh, Judit, additional, Lengyel, Zsuzsanna, additional, Emri, Gabriella, additional, Liszkay, Gabriella, additional, Ladányi, Andrea, additional, Polini, Beatrice, additional, Fogli, Stefano, additional, Carpi, Sara, additional, Pardini, Barbara, additional, Naccarati, Alessio, additional, Dubbini, Nevio, additional, Breschi, Maria Cristina, additional, Romanini, Antonella, additional, Nieri, Paola, additional, Morgese, Francesca, additional, Soldato, Davide, additional, Pagliaretta, Silvia, additional, Giampieri, Riccardo, additional, Brancorsini, Donatella, additional, Rinaldi, Silvia, additional, Torniai, Mariangela, additional, Campanati, Anna, additional, Ganzetti, Giulia, additional, Offidani, Annamaria, additional, Giacchetti, Alfredo, additional, Ricotti, Giuseppe, additional, Savini, Agnese, additional, Onofri, Azzurra, additional, Bianchi, Francesca, additional, Berardi, Rossana, additional, Galdo, Giovanna, additional, Orlandino, Gianfranco, additional, Serio, Salvatore, additional, Massariello, Domenico, additional, Fabrizio, Tommaso, additional, Montagnani, Valentina, additional, Benelli, Matteo, additional, Apollo, Alessandro, additional, Pescucci, Chiara, additional, Licastro, Danilo, additional, Urso, Carmelo, additional, Gerlini, Gianni, additional, Borgognoni, Lorenzo, additional, Luzzatto, Lucio, additional, Stecca, Barbara, additional, Gambale, Elisabetta, additional, Tinari, Camilla, additional, Quinzii, Alberto, additional, Cortellini, Alessio, additional, Carella, Consiglia, additional, De Tursi, Michele, additional, De Francesco, Adele Emanuela, additional, De Fina, Mariarosanna, additional, Zito, Maria Cristina, additional, Bisceglia, Maria Dezia, additional, Esposito, Stefania, additional, Fersini, Giuseppina, additional, Morello, Silvana, additional, Sorrentino, Claudia, additional, Pinto, Aldo, additional, Di Sarno, Antonella, additional, Bianco, Antonella, additional, D’Aniello, Carmine, additional, Andreozzi, Francesca, additional, Festina, Lucia, additional, Vanella, Vito, additional, Montesarchio, Vincenzo, additional, Kotlan, Beatrix, additional, Godeny, Maria, additional, Emil, Farkas, additional, Toth, Laszlo, additional, Horvath, Szabolcs, additional, Eles, Klara, additional, Savolt, Akos, additional, Szollar, Andras, additional, Kasler, Miklós, additional, Yiu, Daniel, additional, Grizzi, Fabio, additional, Patrinicola, Federica, additional, Chiriva-Internati, Maurizio, additional, Motta, Stefania, additional, Monti, Marcello, additional, Benini, Lavinia, additional, Ugel, Stefano, additional, Cingarlini, Sara, additional, Fiore, Alessandra, additional, Grego, Elisabetta, additional, Tortora, Giampaolo, additional, Bronte, Vincenzo, additional, Tondulli, Luca, additional, Di Monta, Gianluca, additional, Caracò, Corrado, additional, Marone, Ugo, additional, Festino, Lucia, additional, and Mozzillo, Nicola, additional
- Published
- 2017
- Full Text
- View/download PDF
18. Pharmacovigilance in Italy: An overview
- Author
-
Mazzitello, Carmela, primary, Esposito, Stefania, additional, De Francesco, Adele E., additional, Capuano, Annalisa, additional, Russo, Emilio, additional, and De Sarro, Giovambattista, additional
- Published
- 2013
- Full Text
- View/download PDF
19. Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
- Author
-
Hirsh, Vera, Pignata, Sandro, Bersanelli, Melissa, Gnetti, Letizia, Azzoni, Cinzia, Bottarelli, Lorena, Gasparro, Donatello, Leonardi, Francesco, Silini, Enrico Maria, Buti, Sebastiano, Wennerberg, Erik, Mediero, Aranzazu, Cronstein, Bruce, Formenti, Silvia, Demaria, Sandra, Vanpouille-Box, Claire, Pilones, Karsten, Rudqvist, Nils, Diamond, Julie, Morris, Zachary S., Guy, Emily I., Francis, David M., Gressett, Monica M., Armstrong, Eric A., Huang, Shyhmin, Gilles, Stephen D., Korman, Alan J., Hank, Jacquelyn A., Hoefges, Anna, Rakhmilevich, Alexander L., Harari, Paul M., Sondel, Paul M., Hailemichael, Yared, Overwijk, Willem W., Straten, Per thor, Lugli, Alessandro, Dawson, Heather, Blank, Annika, Zlobec, Inti, Fattore, Luigi, Costantini, Susan, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Laganà, Alessandro, Malpicci, Debora, Ruggiero, Ciro Francesco, Pisanu, Maria Elena, Noto, Alessia, De Vitis, Claudia, Croce, Carlo Maria, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro, Postow, Michael, Luke, Jason, Stroncek, David, Castiello, Luciano, Chen, Wenjing, Jin, Ping, Ren, Jiaqiang, Sabatino, Marianna, Ferrone, Soldano, Duong, Connie PM, Vetizou, Marie, Zitvogel, Laurence, Occelli, Marcella, Cauchi, Carolina, Sciancalepore, Grazia, Lo Nigro, Cristiana, Rovera, Michela, Varamo, Chiara, Vivenza, Daniela, Seia, Zelda, Palazzini, Stefania, Errico, Fabiana, Basso, Davide, Quaranta, Laura, Forte, Giuseppe, Lavagna, Fulvio, Violante, Silvia, Bosio, Paolo, Lattanzio, Laura, Merlano, Marco Carlo, Moogk, Duane, Zhong, Shi, Yu, Zhiya, Liadi, Ivan, Rittase, William, Fang, Victoria, Dougherty, Janna, Perez-Garcia, Arianne, Osman, Iman, Zhu, Cheng, Varadarajan, Navin, Restifo, Nicholas P., Frey, Alan, Krogsgaard, Michelle, Balatoni, Timea, Moho, Anita, Sebestyén, Timea, Varga, Anita, Oláh, Judit, Lengyel, Zsuzsanna, Emri, Gabriella, Liszkay, Gabriella, Ladányi, Andrea, Polini, Beatrice, Fogli, Stefano, Carpi, Sara, Pardini, Barbara, Naccarati, Alessio, Dubbini, Nevio, Breschi, Maria Cristina, Romanini, Antonella, Nieri, Paola, Morgese, Francesca, Soldato, Davide, Pagliaretta, Silvia, Giampieri, Riccardo, Brancorsini, Donatella, Rinaldi, Silvia, Torniai, Mariangela, Campanati, Anna, Ganzetti, Giulia, Offidani, Annamaria, Giacchetti, Alfredo, Ricotti, Giuseppe, Savini, Agnese, Onofri, Azzurra, Bianchi, Francesca, Berardi, Rossana, Galdo, Giovanna, Orlandino, Gianfranco, Serio, Salvatore, Massariello, Domenico, Fabrizio, Tommaso, Montagnani, Valentina, Benelli, Matteo, Apollo, Alessandro, Pescucci, Chiara, Licastro, Danilo, Urso, Carmelo, Gerlini, Gianni, Borgognoni, Lorenzo, Luzzatto, Lucio, Stecca, Barbara, Gambale, Elisabetta, Tinari, Camilla, Quinzii, Alberto, Cortellini, Alessio, Carella, Consiglia, De Tursi, Michele, De Francesco, Adele Emanuela, De Fina, Mariarosanna, Zito, Maria Cristina, Bisceglia, Maria Dezia, Esposito, Stefania, Fersini, Giuseppina, Morello, Silvana, Sorrentino, Claudia, Pinto, Aldo, Di Sarno, Antonella, Bianco, Antonella, D’Aniello, Carmine, Andreozzi, Francesca, Festina, Lucia, Vanella, Vito, Montesarchio, Vincenzo, Kotlan, Beatrix, Godeny, Maria, Emil, Farkas, Toth, Laszlo, Horvath, Szabolcs, Eles, Klara, Savolt, Akos, Szollar, Andras, Kasler, Miklós, Yiu, Daniel, Grizzi, Fabio, Patrinicola, Federica, Chiriva-Internati, Maurizio, Motta, Stefania, Monti, Marcello, Benini, Lavinia, Ugel, Stefano, Cingarlini, Sara, Fiore, Alessandra, Grego, Elisabetta, Tortora, Giampaolo, Bronte, Vincenzo, Tondulli, Luca, Di Monta, Gianluca, Caracò, Corrado, Marone, Ugo, Festino, Lucia, and Mozzillo, Nicola
- Published
- 2017
- Full Text
- View/download PDF
20. Pharmacovigilance in Italy: An overview
- Author
-
Carmela Mazzitello, Emilio Russo, Annalisa Capuano, Giovambattista De Sarro, Adele Emanuela De Francesco, Stefania Esposito, Mazzitello, Carmela, Esposito, Stefania, De Francesco, Adele, Capuano, Annalisa, Russo, Emilio, and De Sarro, Giovambattista
- Subjects
Pharmacology ,medicine.medical_specialty ,Pediatrics ,ADR ,Italian ,business.industry ,MEDLINE ,Alternative medicine ,Legislation ,Legislature ,Review Article ,legislation ,medicine.disease ,Directive ,Transparency (behavior) ,monitoring ,Pharmacovigilance ,Agency (sociology) ,medicine ,Pharmacology (medical) ,Medical emergency ,AIFA ,business ,ADRs - Abstract
Introduction: Spontaneous reporting of adverse drug reactions (ADRs) is the basis of pharmacovigilance. In fact, ADRs are associated with a high degree of morbidity and mortality. However, underreporting by all healthcare professionals remains the major problem in Italy and in the rest of the world. The dissemination of pharmacovigilance knowledge among Italian healthcare professionals, and the new pharmacovigilance regulations may promote the early detection and reporting of ADRs. This review examines the legislative framework concerning the pharmacovigilance in Italy. Materials and Methods: The information was collected from scientific articles and the websites of the Italian Ministry of Health and the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA). Results: The pharmacovigilance system, both in Italy and Europe, has undergone profound changes. European legislation on pharmacovigilance has been changed in 2010 according to the EU Regulation 1235/2010 and Directive 2010/84/EU. Basically, the changes tend to increase the efficiency, speed and transparency of pharmacovigilance activities. The new Regulation (1235/2010) and the Directive (2010/84/EU) aim to strengthen the system of pharmacovigilance, establish more precisely who is obliged to do what, and allow faster and easier circulation and retrieval of information about ADRs. Conclusion: A greater knowledge on what is the Italian pharmacovigilance legislation will be useful to improve the status of ADRs reporting and spread the culture of spontaneous reporting.
- Published
- 2013
- Full Text
- View/download PDF
21. Pattern of triptans use: a retrospective prescription study in Calabria, Italy.
- Author
-
Scuteri D, Adornetto A, Rombolà L, Naturale MD, De Francesco AE, Esposito S, Zito M, Morrone LA, Bagetta G, Tonin P, and Corasaniti MT
- Abstract
Triptans are 5-hydroxytryptamine 1B/1D receptor agonists used in moderate to severe migraine attacks as first line when non-specific, symptomatic, nonsteroidal anti-inflammatory drugs are not effective. To gain insight in the treatment of migraine in the regional context, this retrospective (from January to August of the years 2017 and 2018) study aimed at monitoring the use of triptans approved by the regional health authority in Calabria. The data demonstrate that the overall treatment of migraine with triptans in the different provinces of Calabria falls in the average regional prescription/dispensation. Interestingly, Crotone showed a trend to an increased amount of defined daily dose/1000 inhabitants per day. The present analysis might stand for homogeneity of treatment of migraineurs in Calabria and highlights the need for better understanding the apparent differences in the local pattern of almotriptan use to improve the appropriateness., Competing Interests: None
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.